hypogonadism; kisspeptin10; compounding; fda 503a
-
FDA Evaluation of Kisspeptin-10: Accordingly, we propose not adding kisspeptin-10 to the 503A Bulks List
I. INTRODUCTION Kisspeptin-10 was nominated for inclusion on the list of bulk drug substances that can be used in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act).1 Kisspeptin-10 was evaluated for the treatment of secondary hypogonadism in men.2,3...- madman
- Thread
- hypogonadism; kisspeptin10; compounding; fda 503a
- Replies: 2
- Forum: General Peptide Use & Information
Share this page
Sponsors
